Delivery Order SPE2DB24D3015-SPE2DB25FFXQM

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, worth $6,394.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,961,976 doxycycline 50 mg tablets in 60-count packages. The contract type is a delivery order with a firm fixed price and an ultimate completion date of January 17, 2025. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,624.41, is for the delivery of 4,543,086,193 doxycycline 100mg tablets in packages of 500. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,324.65 and is a delivery order with a firm fixed price pricing type. The contract is for the supply of 4,567,254,166 units of Doxycycline Hyclate 100 mg tablets, a pharmaceutical product used in medical treatment. The contract has an ultimate completion date of February 13, 2025. This...
This federal contract award, valued at $2,727.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564997075 - Doxycycline 50 mg Tablets, 60s, with a completion date of June 26, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $2,381.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,792,342 units of Doxycycline Hyclate 100 mg tablets, a common antibiotic medication, with a completion date of June 4, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $20,707.19, is for the delivery of 4,564,945,167 units of Doxycycline 50 mg tablets. This is a firm fixed-price delivery order contract with a completion date of June 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of doxycycline 50 mg tablets. The contract has a ceiling value of $13,221.43 and an ultimate completion date of May 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award, valued at $78,624.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order that covers the supply of 4,536,279,049 units of Doxycycline 100mg tablets. The contract has an ultimate completion date of December 23, 2016 and was awarded on November 28, 2016. Amerisourcebergen holds a significant...
This federal contract award, with ID SPE2DB22D3501|SPE2DB23FTR82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,255,906 units of doxycycline hyclate 100 mg tablets. The $1,644.16 firm-fixed-price delivery order has an ultimate completion date of December 5, 2022. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, holds significant...
This federal contract award, valued at $19,844.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the delivery of 4565098325 - DOXYCYCLINE 50 MG TABLET 60S, a pharmaceutical product. The...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXQM
    Delivery Order

This federal contract award, valued at $2,405.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4566868393 - Doxycycline 50 mg Tablet 60s. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 9, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is not designated with a set-aside requirement, indicating open competition.

Generated 5/21/25, 9:43 AM